How has been the historical performance of SMS Lifesciences?
SMS Lifesciences has shown fluctuating historical performance, with net sales increasing to 344.72 Cr in March 2025, alongside significant growth in profits, including a profit before tax rise to 26.19 Cr. The company has demonstrated improved operational efficiency and positive cash flow trends in recent years.
Answer:The historical performance of SMS Lifesciences shows a fluctuating trend in net sales and profits over the years, with a notable increase in recent periods.Breakdown:
SMS Lifesciences reported net sales of 344.72 Cr in March 2025, up from 305.96 Cr in March 2024, but down from 349.74 Cr in March 2022. The total operating income followed a similar trend, reaching 344.72 Cr in March 2025. The company's total expenditure, excluding depreciation, was 299.68 Cr in March 2025, which is an increase from 274.84 Cr in March 2024. Operating profit (PBDIT) for March 2025 was 49.90 Cr, significantly higher than 34.95 Cr in March 2024, indicating improved operational efficiency. Profit before tax also saw a substantial rise to 26.19 Cr in March 2025 from 9.85 Cr in March 2024, while profit after tax increased to 18.73 Cr from 6.33 Cr in the previous year. The consolidated net profit for March 2025 was 20.11 Cr, compared to 9.09 Cr in March 2024. The company’s total assets decreased slightly to 389.99 Cr in March 2025 from 391.33 Cr in March 2024, while total liabilities also saw a minor decline to 389.99 Cr. Cash flow from operating activities improved to 34.00 Cr in March 2025, up from 24.00 Cr in March 2024, reflecting a positive cash flow trend. Overall, SMS Lifesciences has shown resilience and growth in its financial performance over the recent years.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
